NSAH depresses dGTP and dATP levels in the dNTP pool causing S-phase arrest, providing evidence for RR inhibition in cells.
NSAH (0-10 μM, 2, 6, 24, or 72 h) exhibits potent anti-tumor activity in 3 cancer cell lines.
NSAH blocks S-phase progression well to the extent and timing of the decreases in dATP and dGTP.
Cell Viability Assay
| Cell Line: |
MDA-231, HCT116 and Panc1 cancer cell lines. |
| Concentration: |
0-10 μM. |
| Incubation Time: |
2, 6, 24, or 72 h. |
| Result: |
Resulted in IC50 values ranging from 220 to 500 nM. |